help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freemark, M.
Right arrow Articles by Kelly, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freemark, M.
Right arrow Articles by Kelly, P. A.
Endocrinology Vol. 142, No. 2 532-537
Copyright © 2001 by The Endocrine Society


ARTICLES

Body Weight and Fat Deposition in Prolactin Receptor-Deficient Mice1

Michael Freemark, Don Fleenor, Phyllis Driscoll, Nadine Binart and Paul A. Kelly

Departments of Pediatrics (M.F., D.F., P.D.) and Cell Biology (M.F.), Duke University Medical Center, Durham, North Carolina 27710; and INSERM U-344, Faculté de Médecine Necker, Paris, France

Address all correspondence and requests for reprints to: Dr. Michael Freemark, Department of Pediatrics, Box 3080, Duke University Medical Center, Durham, North Carolina 27710. E-mail: freem001{at}mc.duke.edu

To explore the roles of the lactogens in adipose tissue development and function, we measured body weight, abdominal fat content, and plasma leptin concentrations in a unique model of lactogen resistance: the PRL receptor (PRLR)-deficient mouse. The absence of PRLRs in knockout mice was accompanied by a small (5–12%), but progressive, reduction in body weight after 16 weeks of age. Females were affected to a greater degree than males. The reduction in weight in female PRLR-deficient mice (age 8–9 months) was associated with a 49% reduction in total abdominal fat mass and a 29% reduction in fat mass expressed as a percentage of body weight. Lesser reductions were noted in male mice. Plasma leptin concentrations were reduced in females but not in males. That the reductions in abdominal fat may reflect in part the absence of lactogen action in the adipocyte is suggested by the demonstration of PRLR messenger RNA in normal mouse white adipose tissue. Nevertheless, steady state levels of PRLR messenger RNA in mature adipocytes are very low, suggesting that the effects of lactogens might be mediated by other hormones or cellular growth factors. Our observations suggest roles for the lactogens in adipose tissue growth and metabolism in pregnancy and postnatal life.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev., February 1, 2008; 29(1): 1 - 41.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Naef and B. Woodside
Prolactin/Leptin Interactions in the Control of Food Intake in Rats
Endocrinology, December 1, 2007; 148(12): 5977 - 5983.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. H. Schmitz, H. Lin, M. D. Sammel, C. R. Gracia, D. B. Nelson, S. Kapoor, T. L. DeBlasis, and E. W. Freeman
Association of Physical Activity with Reproductive Hormones: The Penn Ovarian Aging Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2042 - 2047.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
G.D. Cooper, L.C. Pickavance, J.P.H. Wilding, J.A. HarroLd, J.C.G. HaLford, and A.J. Goudie
Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities
J Psychopharmacol, June 1, 2007; 21(4): 405 - 413.
[Abstract] [PDF]


Home page
J EndocrinolHome page
D. J Flint, N. Binart, S. Boumard, J. J Kopchick, and P. Kelly
Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity.
J. Endocrinol., October 1, 2006; 191(1): 101 - 111.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. R. LaPensee, N. D. Horseman, P. Tso, T. D. Brandebourg, E. R. Hugo, and N. Ben-Jonathan
The Prolactin-Deficient Mouse Has an Unaltered Metabolic Phenotype
Endocrinology, October 1, 2006; 147(10): 4638 - 4645.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Gentili, M. J. Waters, and I. C. McMillen
Differential regulation of suppressor of cytokine signaling-3 in the liver and adipose tissue of the sheep fetus in late gestation
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1044 - R1051.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Kok, F. Roelfsema, J. G. Langendonk, C. C. de Wit, M. Frolich, J. Burggraaf, A. E. Meinders, and H. Pijl
Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E218 - E224.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kedzia, L. Lacroix, N. Ameur, T. Ragot, P. A. Kelly, B. Caillou, and N. Binart
Medullary Thyroid Carcinoma Arises in the Absence of Prolactin Signaling
Cancer Res., September 15, 2005; 65(18): 8497 - 8503.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Fleenor, J. Oden, P. A. Kelly, S. Mohan, S. Alliouachene, M. Pende, S. Wentz, J. Kerr, and M. Freemark
Roles of the Lactogens and Somatogens in Perinatal and Postnatal Metabolism and Growth: Studies of a Novel Mouse Model Combining Lactogen Resistance and Growth Hormone Deficiency
Endocrinology, January 1, 2005; 146(1): 103 - 112.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S Viengchareun, H Bouzinba-Segard, J-P Laigneau, M-C Zennaro, P A Kelly, A Bado, M Lombes, and N Binart
Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes
J. Mol. Endocrinol., December 1, 2004; 33(3): 679 - 691.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Kok, F. Roelfsema, M. Frolich, A. E. Meinders, and H. Pijl
Prolactin Release Is Enhanced in Proportion to Excess Visceral Fat in Obese Women
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4445 - 4449.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Q. Xiao, K. L. Grove, B. E. Grayson, and M. S. Smith
Inhibition of Uncoupling Protein Expression during Lactation: Role of Leptin
Endocrinology, February 1, 2004; 145(2): 830 - 838.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. M. Thompson, D. A. S. Gill, R. Davies, N. Loveridge, P. A. Houston, I. C. A. F. Robinson, and T. Wells
Ghrelin and Des-Octanoyl Ghrelin Promote Adipogenesis Directly in Vivo by a Mechanism Independent of the Type 1a Growth Hormone Secretagogue Receptor
Endocrinology, January 1, 2004; 145(1): 234 - 242.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Shang and M. J. Waters
Constitutively Active Signal Transducer and Activator of Transcription 5 Can Replace the Requirement for Growth Hormone in Adipogenesis of 3T3-F442A Preadipocytes
Mol. Endocrinol., December 1, 2003; 17(12): 2494 - 2508.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Ling, L. Svensson, B. Oden, B. Weijdegard, B. Eden, S. Eden, and H. Billig
Identification of Functional Prolactin (PRL) Receptor Gene Expression: PRL Inhibits Lipoprotein Lipase Activity in Human White Adipose Tissue
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1804 - 1808.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Zinger, M. McFarland, and N. Ben-Jonathan
Prolactin Expression and Secretion by Human Breast Glandular and Adipose Tissue Explants
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 689 - 696.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Nanbu-Wakao, Y. Morikawa, I. Matsumura, Y. Masuho, M.-a. Muramatsu, E. Senba, and H. Wakao
Stimulation of 3T3-L1 Adipogenesis by Signal Transducer and Activator of Transcription 5
Mol. Endocrinol., July 1, 2002; 16(7): 1565 - 1576.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin
Understanding adipose tissue development from transgenic animal models
J. Lipid Res., June 1, 2002; 43(6): 835 - 860.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Diaz-Torga, C. Feierstein, C. Libertun, D. Gelman, M. A. Kelly, M. J. Low, M. Rubinstein, and D. Becu-Villalobos
Disruption of the D2 Dopamine Receptor Alters GH and IGF-I Secretion and Causes Dwarfism in Male Mice
Endocrinology, April 1, 2002; 143(4): 1270 - 1279.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Ling and H. Billig
PRL Receptor-Mediated Effects in Female Mouse Adipocytes: PRL Induces Suppressors of Cytokine Signaling Expression and Suppresses Insulin-Induced Leptin Production in Adipocytes in Vitro
Endocrinology, November 1, 2001; 142(11): 4880 - 4890.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society